We need to update the first and third addresses as shown above. Furthermore, "zero" has been modified and replaced by "---" in [Table 3](#tab3){ref-type="table"}.

###### 

Efficacy of 61 chemotherapy regimens in 32 patients with measurable disease during first or any subsequent line of therapy.

  ------------------------------------------------------------------------------------------------------------------------
                                    *N*   CR    PR    Overall response (%)   SD         PD         Unknown response (%)\
  --------------------------------- ----- ----- ----- ---------------------- ---------- ---------- -----------------------
  VA                                6     ---   1     1 (17%)                5          ---        ---

  IVA                               13    3     1     4 (30%)                9          ---        ---

  VAC                               3     ---   ---   ---                    1          1          1

  VAC and tamoxifen                 1     ---   ---   ---                    1          ---        ---

  Vinblastine-MTX                   14    ---   7     7 (50%)                5          1          1

  Vinblastine-MTX-tamoxifen         7     ---   3     3 (43%)                3          ---        1

  Doxorubicin with other agents\*   5     ---   2     2 (40%)                ---        3          ---

  Imatinib mesylate                 2     ---   ---   ---                    2          ---        ---

  Others^+^                         10    ---   2     2 (20%)                1          7          ---

                                                                                                   

  Total                             61    3     16    19 (31%)               27 (44%)   12 (20%)   3 (5%)
  ------------------------------------------------------------------------------------------------------------------------

VA: vincristine and dactinomycin; IVA: ifosfamide, vincristine and dactinomycin; VAC: vincristine, dactinomycin, and cyclophosphamide; MTX: methotrexate. *N*: number of patients; CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease.

\*Doxorubicin with vincristine, cisplatin, ifosfamide, cyclophosphamide, or tamoxifen.

^+^Others: VINCAEPI (vincristine, carboplatin, and VM 26), MMT95 protocol (IVA, etoposide, epirubicin, and carboplatin), dactinomycin alone, etoposide-ifosfamide, etoposide alone, and carboplatin.
